Guangzhou Pharmaceutical Import and Export Corporation

home products Chemical Medicine-Antibiotic Roxithromycin Capsules/ Dispersible Tablets

Roxithromycin Capsules/ Dispersible Tablets

Product Details:

Dosage Form Capsules
Place of Origin Guangdong, China (Mainland)
Brand Name BYS

Detailed Product Description


Product Category:Antibiotic

Generic Name: Roxithromycin Capsules
Main Ingredients: Roxithromycin

Descriptions: The content of XinKaLuo is a white or whitish powder and granules.

Indications: XinKaLuo is indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: pharyngitis and tonsillitis caused by Micrococcus scarlatinae, nasosinusitis, otitis media, acute and chronic bronchitis caused by susceptible microorganisms, pneumonia caused by Mycoplasma pneumonia and Chlamydia pneumoniae, urinary tract infections and cervicitis caused by Chlamydiae trachomatis, skin structure infections introduced by susceptible microorganisms.

Usage & Dosage: Oral administraion in a fasting state. The usual course of treatment is 5 to 12 days.

Adult - 0.15g (2 capsules) a time, twice a day; or 0.3g (4 capsules) a time, once every day.

Children - 2.5 to 5mg/kg a time, twice a day. Or follow the instruction of your doctors.

Contraindications: XinKaLuo is contraindicated in patients with known hypersensitivity to the Macrolides group of antibiotics, roxithromycin and any other ingredient consisting of the drug.

Strength: 75mg

Packing Specification:12 caps/blister pack/box × 400 boxes/carton

Drug Approval Number: GuoYaoZhunZi H20064359

Storage: Keep airtight in a dry place. Away from light.

Drug Name: Roxithromycin Dispersible Tablets


Product Category: Antibiotic
Medicament Form: Dispersible Tablets
Brand Name: XinKaLuo
Generic Name: Roxithromycin Dispersible Tablets
Main Ingredients: Roxithromycin

Descriptions: It is a white or whitish tablet.

Indications: XinKaLuo is indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: pharyngitis and tonsillitis caused by Micrococcus scarlatinae; nasosinusitis, otitis media, acute and chronic bronchitis caused by susceptible microorganisms; pneumonia caused by Mycoplasma pneumonia and Chlamydia pneumoniae; urinary tract infections and cervicitis caused by Chlamydiae trachomatis; skin structure infections introdused by susceptible microorganisms.

Usage & Dosage: Oral administraion in a fasting state. The usual course of treatment is 5 to 12 days.

Adult -150mg each time, twice a day; or 0.3g each time, once a day.

Children - 2.5 to 5mg/kg each time, twice a day.
Contraindications: XinKaLuo is contraindicated in patients with known hypersensitivity to the Macrolides group of antibiotics and roxithromycin.

Strength: 150mg
Packing Specification: 6 tabs/blister pack/box × 600 boxes/carton

Drug Approval Number: GuoYaoZhunZi H20064485

Storage: Keep airtight in a dry (normal temperature 10~30) place. Away from light.

Roxithromycin Capsules/ Dispersible Tablets Roxithromycin Capsules/ Dispersible Tablets

Send your message to this supplier
« Prev Product ... 15 16 17 Next Product »

Other Products from this Supplier

Company Info

Guangzhou Pharmaceutical Import and Export Corporation
[China (Mainland)]
[Verified Member]

City: Guangzhou
Province/State: Guangdong
Country/Region : China (Mainland)

Business Type:Manufacturer, Trading Company

View Contact Details

Email this page Bookmark this page Print this Page